Literature DB >> 16646301

[Pathogenesis of chronic obstructive pulmonary disease. Cellular mechanisms (part I)].

Robert M Mróz1, Patryk Szulakowski, Wliadysław Pierzchala, Elzbieta Chyczewska, William MacNee.   

Abstract

Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality worldwide. Smoking is considered the major cause of the disease. All smokers develop airway inflammation through oxidative stress with macrophages, neutrophiles, lymphocytes, eosinophils, NK-cells and mediators involved. Macrophages through the activation of Nuclear Factor kappa B (NF.-kappaB) release proinflammatory mediators, lymphocyte chemotactic agents and elastolytic enzymes, activate neutrophil driven serine proteases and GM-CSF. Neutrophiles release IL-8 which in turn recruits neutrophils to the airways. In response to cigarette smoke lung epithelium may release TNF-alpha, TGF-beta, IL-1beta, GM-CSF, IL-8 reactive oxygen species (ROS). Increased number of lymphocyte T CD8+ and CD4+ subpopulations may lead to lung epithelium cells apoptosis and necrosis through perphorines and granzyme-B and TNF-alpha activation. Moreover, increased expression of IL-6, IL-10, IL-12, IL-13, and INF-gamma is observed. Authors indicate the possibility of new treatment strategies such as: agents directed against adhesion molecules, chemokines, phosphodiesterase 4, p38 MAPK, NF.-kappaB phosphoinositide-3-kinase gamma, TGF-beta, NOS synthase, serine proteinases and matrix metalloproteinases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16646301

Source DB:  PubMed          Journal:  Wiad Lek        ISSN: 0043-5147


  2 in total

1.  Proinflammatory mediators disrupt glucose homeostasis in airway surface liquid.

Authors:  James P Garnett; Trang T Nguyen; James D Moffatt; Elizabeth R Pelham; Kameljit K Kalsi; Emma H Baker; Deborah L Baines
Journal:  J Immunol       Date:  2012-05-23       Impact factor: 5.422

2.  Airway inflammation and anti-protease defences rapidly improve during treatment of an acute exacerbation of COPD.

Authors:  Sushil Pant; Eugene H Walters; Anne Griffiths; Richard Wood-Baker; David P Johns; David W Reid
Journal:  Respirology       Date:  2009-05       Impact factor: 6.424

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.